What is the ticker symbol for Metagenomi?

Metagenomi trades under the ticker MGX on NASDAQ.

What sector does Metagenomi operate in?

Metagenomi is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze MGX in a portfolio?

PortView shows MGX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Metagenomi (MGX) Stock Analysis

NASDAQHealthcareBiotechnology

$1.16-0.85%

1-year price historyRange $1.14 – $3.35

52-week range$1.16

$1.13$3.95

What Metagenomi does

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

Key metrics

Market cap

$43.67M

P/E (TTM)

-0.47

EPS (TTM)

$-2.49

Beta

0.67

Dividend yield

0.00%

Revenue / share

$0.36

50-day avg

$1.23

200-day avg

$1.44

52-week high

$3.95

52-week low

$1.13

CEO

Jian Irish

ETFs linked to MGX

Broad-market and Healthcare sector ETFs an investor holding Metagenomi is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how MGX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MGX in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Metagenomi?: Metagenomi trades under the ticker MGX on NASDAQ.
Which exchange is MGX listed on?: MGX is listed on NASDAQ.
What sector does Metagenomi operate in?: Metagenomi is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze MGX in a portfolio?: PortView shows MGX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.